This standard is based on CG187.
This standard should be read in conjunction with QS100, QS99, QS15 and QS9.
Introduction Introduction
This quality standard covers the care of adults (aged 18 years or older) who have a diagnosis of acute heart failure or are being investigated for acute heart failure. The long-term management of chronic heart failure is not covered in the quality standard because it is covered by a separate NICE guideline (CG108) and quality standard referral (QS9). For more information see the topic overview.
Why this quality standard is needed
Acute heart failure refers to the rapid onset of a clinical syndrome where the heart is unable to pump sufficient blood to provide for the needs of the body. It is caused by dysfunction of the heart due to muscle damage (systolic or diastolic dysfunction), valvular dysfunction, arrhythmias or other rare causes. Acute heart failure can present as new-onset heart failure in people without known cardiac dysfunction, or as acute decompensation of chronic heart failure.
Acute heart failure is a common cause of admission to hospital (over 67,000 admissions in England and Wales a year) and is the leading cause of hospital admission in people 65 years or older in the UK.
The quality standard is expected to contribute to improvements in the following outcomes: mortality rates incidence of major cardiovascular events (non-fatal myocardial infarction, stroke) length of hospital stay readmission rates incidence of adverse events (withdrawal of beta-blockers and other disease-modifying drugs) quality of life.
Acute heart failure (QS103)
How this quality standard supports delivery of outcome frameworks NICE quality standards are a concise set of prioritised statements designed to drive measurable improvements in the 3 dimensions of quality -patient safety, patient experience and clinical effectiveness -for a particular area of health or care. They are derived from high-quality guidance, such as that from NICE or other sources accredited by NICE. This quality standard, in conjunction with the guidance on which it is based, should contribute to the improvements outlined in the following 2 outcomes frameworks published by the Department of Health: Tables 1 and 2 show the outcomes, overarching indicators and improvement areas from the frameworks that the quality standard could contribute to achieving.
T 
Indicators in italics are in development
Acute heart failure (QS103)
Patient experience and safety issues
Ensuring that care is safe and that people have a positive experience of care is vital in a high-quality service. It is important to consider these factors when planning and delivering services relevant to acute heart failure.
NICE has developed guidance and an associated quality standard on patient experience in adult NHS services (see the NICE pathway on patient experience in adult NHS services), which should be considered alongside this quality standard. They specify that people receiving care should be treated with dignity, have opportunities to discuss their preferences, and are supported to understand their options and make fully informed decisions. They also cover the provision of information to patients and service users. Quality statements on these aspects of patient experience are not usually included in topic-specific quality standards. However, recommendations in the development sources for quality standards that impact on patient experience and are specific to the topic are considered during quality statement development.
Coordinated services
The quality standard for acute heart failure specifies that services should be commissioned from and coordinated across all relevant agencies encompassing the whole acute heart failure care
Acute heart failure (QS103) pathway. A person-centred, integrated approach to providing services is fundamental to delivering high-quality care to adults with acute heart failure.
The Health and Social Care Act 2012 sets out a clear expectation that the care system should consider NICE quality standards in planning and delivering services, as part of a general duty to secure continuous improvement in quality. Commissioners and providers of health and social care
should refer to the library of NICE quality standards when designing high-quality services. Other quality standards that should also be considered when choosing, commissioning or providing a high-quality acute heart failure service are listed in related quality standards.
T Tr raining and competencies aining and competencies
The quality standard should be read in the context of national and local guidelines on training and competencies. All healthcare professionals involved in assessing, caring for and treating adults with acute heart failure should have sufficient and appropriate training and competencies to deliver the actions and interventions described in the quality standard. Quality statements on staff training and competency are not usually included in quality standards. However, recommendations in the development source on specific types of training for the topic that exceed standard professional training are considered during quality statement development.
Role of families and carers Role of families and carers
Quality standards recognise the important role families and carers have in supporting adults with acute heart failure. If appropriate, healthcare professionals should ensure that family members and carers are involved in the decision-making process about investigations, treatment and care.
Acute heart failure (QS103) Statement 3. Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
Statement 4. Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission.
Statement 5. Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin-converting enzyme (ACE) inhibitor and an aldosterone antagonist.
Statement 6. Adults with acute heart failure have a follow-up clinical assessment by a member of the community-or hospital-based specialist heart failure team within 2 weeks of hospital discharge.
Acute heart failure (QS103) 
Rationale
Natriuretic peptide testing (B-type natriuretic peptide [BNP] or N-terminal pro-B-type natriuretic peptide [NT-proBNP] ) is an important tool for rapidly assessing adults presenting to hospital with new suspected acute heart failure. It can be used to rule out a diagnosis of heart failure or to see if further investigation with echocardiography is needed. It can save time and distress for the adult presenting with new suspected acute heart failure.
Quality measures
Structure Structure
Evidence of local arrangements to ensure that adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide. Denominator -the number of presentations of adults to hospital with new suspected acute heart failure. Acute heart failure (QS103) b) Proportion of hospitals that use appropriate assay thresholds of plasma BNP less than 100 ng/ litre and plasma NT-proBNP less than 300 ng/litre.
Data sour

Numerator -the number in the denominator that use appropriate assay thresholds of plasma BNP less than 100 ng/litre and plasma NT-proBNP less than 300 ng/litre.
Denominator -the number of hospitals in England to which people may present with suspected acute heart failure. 
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (cardiac service providers) ensure that adults presenting to hospital with new suspected acute heart failure have a single measurement of natriuretic peptide that is undertaken by the cardiac team to rule out a diagnosis of heart failure. Also, hospitals in England to which people may present with suspected acute heart failure ensure they use appropriate assay thresholds of plasma BNP less than 100 ng/litre and plasma NT-proBNP less than 300 ng/litre.
Acute heart failure (QS103)
Healthcare professionals Healthcare professionals ensure that adults with new suspected acute heart failure have a single measurement of natriuretic peptide on presentation to hospital to rule out a diagnosis of heart failure.
Commissioners Commissioners (clinical commissioning groups) ensure that adults with new suspected acute heart failure have a single measurement of natriuretic peptide on presentation to hospital to rule out a diagnosis of heart failure.
What the quality statement means for patients, service users and carers
Adults presenting at hospital with new suspected acute heart failure Adults presenting at hospital with new suspected acute heart failure have their natriuretic peptide (also known as BNP or NT-proBNP) level in their blood measured. This test is a quick way for doctors to find out whether the person is likely to have heart failure or if they need further assessment to see if their symptoms are caused by something else.
Source guidance
Acute heart failure (2014) NICE guideline CG187, recommendation 1.2.2 (key priority for implementation)
Definitions of terms used in this quality statement
Natriuretic peptide Natriuretic peptide A protein substance secreted by the wall of the heart when it is stretched or under increased pressure. It has several forms and its level can be raised in a number of conditions, including heart failure. A normal natriuretic peptide level means that heart failure is unlikely, and its measurement can be used to exclude a diagnosis of heart failure.
[Adapted from acute heart failure (NICE guideline CG187) full guideline]
Appropriate assa Appropriate assay thresholds of plasma BNP to assist in ruling out the diagnosis of y thresholds of plasma BNP to assist in ruling out the diagnosis of heart failure heart failure Plasma BNP less than 100 ng/litre Plasma NT-proBNP less than 300 ng/litre.
[Adapted from acute heart failure (NICE guideline CG187) full guideline] Acute heart failure (QS103) Quality statement 2: T Quality statement 2: Tr ransthor ansthoracic doppler 2D echocardiogr acic doppler 2D echocardiograph aphy y
Quality statement
Adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.
Rationale
Performing a transthoracic doppler 2D echocardiogram within 48 hours of hospital admission for adults with new suspected acute heart failure and raised natriuretic peptide levels will enable earlier diagnosis and appropriate management in terms of pharmacological treatment, location of care and relevant input from the specialist heart failure team.
Quality measures
Structure Structure
Evidence of local arrangements to ensure that adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D
echocardiogram within 48 hours of admission.
Data sour
Data source: ce: Local data collection.
Process Process
Proportion of adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels who have a transthoracic doppler 2D echocardiogram within 48 hours of admission.
Numerator -the number in the denominator who have a transthoracic doppler 2D echocardiogram within 48 hours of admission.
Denominator -the number of hospital episodes of adults with new suspected acute heart failure and raised natriuretic peptide levels.
Data sour Data source: ce: Local data collection.
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (cardiac and radiology services) ensure that adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D
Healthcare professionals Healthcare professionals ensure that adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.
Commissioners Commissioners (clinical commissioning groups) ensure that adults admitted to hospital with new suspected acute heart failure and raised natriuretic peptide levels have a transthoracic doppler 2D echocardiogram within 48 hours of admission.
Acute heart failure (QS103) Quality statement 3: Organisation of care -early specialist input Quality statement 3: Organisation of care -early specialist input
Quality statement
Adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
Rationale
A dedicated specialist heart failure team with early involvement is important for cost-effective care. It can also positively contribute to rapid diagnosis, reduced readmissions and better quality of life. Ongoing input of the dedicated specialist heart failure team will also help to ensure appropriate care and make subsequent readmission less likely.
Quality measures
Evidence of local arrangements to ensure that adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
Data sour
Process Process a) Proportion of adults admitted to hospital with acute heart failure who have input within 24 hours of admission from a dedicated specialist heart failure team.
Numerator -the number in the denominator who receive input within 24 hours of admission from a dedicated specialist heart failure team.
Denominator -the number of adults admitted to hospital with acute heart failure. 
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (cardiac service providers) ensure that adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
Healthcare professionals Healthcare professionals ensure that adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
Commissioners Commissioners (clinical commissioning groups) ensure that adults admitted to hospital with acute heart failure have input within 24 hours of admission from a dedicated specialist heart failure team.
What the quality statement means for patients, service users and carers
Adults admitted to hospital with acute heart failure Adults admitted to hospital with acute heart failure have contact with a team within 24 hours of admission that specialises in treating heart failure and that is involved in their early care.
Source guidance
Acute heart failure (2014) NICE guideline CG187, recommendation 1.1.2 (key priority for implementation)
Definitions of terms used in this quality statement
Input within 24 hours of hospital admission Input within 24 hours of hospital admission
Review and address the needs of acute heart failure patients within 24 hours of hospital admission.
[Expert consensus]
Dedicated specialist heart failure team Dedicated specialist heart failure team This specialist inpatient team includes doctors, nurses (including heart failure specialist nurses), pharmacists, physiotherapists and psychologists, and has access to a palliative care specialist and other expertise as required. The team is led by a consultant specialist with a sub-speciality interest in heart failure. This team is based on a cardiology ward but also provides outreach services to heart failure patients on all other wards within the hospital. It is also part of a broader multidisciplinary specialist team working across primary and secondary care, as outlined by NICE guidance.
[Adapted from chronic heart failure (2010) NICE guideline CG108 and expert consensus]
Acute heart failure (QS103) Quality statement 4: Starting or continuing beta-block Quality statement 4: Starting or continuing beta-blocker treatment er treatment
Quality statement
Adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission.
Rationale
In-hospital introduction of beta-blockers is associated with increased use of beta-blockers at follow-up and better long-term outcomes such as fewer adverse events and reduced mortality.
Also, it is important that beta-blocker treatment is continued for adults who are already taking it.
Quality measures
Evidence of local arrangements to ensure that adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission. Numerator -the number in the denominator who are started on beta-blocker treatment during their hospital admission.
Data sour
Denominator -the number of hospital admissions of adults with acute heart failure due to left ventricular systolic dysfunction in which the patient is not already taking a beta-blocker.
b) Proportion of adults with acute heart failure due to left ventricular systolic dysfunction who continue with beta-blocker treatment during their hospital admission.
Acute heart failure (QS103)
Numerator -the number in the denominator who continue beta-blocker treatment during their hospital admission.
Denominator -the number of hospital admissions of adults with acute heart failure due to left ventricular systolic dysfunction. Acute heart failure (QS103)
Data sour
What the quality statement means for service providers, healthcare professionals and commissioners
Service pro Service providers viders (cardiac service providers) ensure that adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission.
Healthcare professionals Healthcare professionals ensure that adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission.
Commissioners Commissioners (clinical commissioning groups) ensure that adults with acute heart failure due to left ventricular systolic dysfunction are started on, or continue with, beta-blocker treatment during their hospital admission.
What the quality statement means for patients, service users and carers
Adults with acute heart failure Adults with acute heart failure due to left ventricular systolic dysfunction (known as LVSD, where the pumping chamber of the heart is not pumping well) start or continue beta-blockers while they are in hospital.
Source guidance
Acute heart failure (2014) NICE guideline CG187, recommendation 1.5.2 (key priority for implementation)
Definitions of terms used in this quality statement
Beta-block Beta-blocker er Treatment for heart failure, heart rhythm disturbances, angina and heart attacks, and high blood pressure.
Acute heart failure (QS103) Quality statement 5: Drug ther Quality statement 5: Drug therap apy y
Quality statement
Adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an angiotensin-converting enzyme (ACE) inhibitor and an aldosterone antagonist.
Rationale
Early initiation of ACE inhibitors and aldosterone antagonists for adults with acute heart failure is positively associated with improved outcomes such as lower mortality and readmission rates. If the ACE inhibitor has intolerable side effects, an angiotensin receptor blocker will be offered.
Quality measures
Evidence of local arrangements to ensure that adults admitted to hospital with acute heart failure and reduced left ventricular ejection fraction are offered an ACE inhibitor and an aldosterone antagonist. 
Data sour
Process Process
Proportion of new hospital admissions for adults with acute heart failure and reduced left ventricular ejection fraction when an ACE inhibitor and an aldosterone antagonist are offered.
Numerator -the number in the denominator treated with an ACE inhibitor and an aldosterone antagonist.
Denominator -the number of new hospital admissions for adults with acute heart failure and reduced left ventricular ejection fraction.
Data sour
Using the quality standard Using the quality standard
Quality measures
The quality measures accompanying the quality statements aim to improve the structure, process and outcomes of care in areas identified as needing quality improvement. They are not a new set of targets or mandatory indicators for performance management.
We have indicated if current national indicators exist that could be used to measure the quality statements. These include indicators developed by the Health and Social Care Information Centre through its Indicators for Quality Improvement Programme. If there is no national indicator that could be used to measure a quality statement, the quality measure should form the basis for audit criteria developed and used locally.
See NICE's what makes up a NICE quality standard? for further information, including advice on using quality measures.
Levels of achievement
Expected levels of achievement for quality measures are not specified. Quality standards are intended to drive up the quality of care, and so achievement levels of 100% should be aspired to (or 0% if the quality statement states that something should not be done). However, NICE recognises that this may not always be appropriate in practice, taking account of safety, choice and professional judgement, and therefore desired levels of achievement should be defined locally.
Using other national guidance and policy documents
Other national guidance and current policy documents have been referenced during the development of this quality standard. It is important that the quality standard is considered alongside the documents listed in development sources.
Div Diversity ersity, equality and language , equality and language During the development of this quality standard, equality issues have been considered and equality assessments are available.
Good communication between healthcare professionals and adults with acute heart failure is essential. Treatment, care and support, and the information given about it, should be culturally appropriate. It should also be accessible to people with additional needs such as physical, sensory or learning disabilities, and to people who do not speak or read English. Adults with acute heart failure should have access to an interpreter or advocate if needed.
Commissioners and providers should aim to achieve the quality standard in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity and foster good relations. Nothing in this quality standard should be interpreted in a way that would be inconsistent with compliance with those duties.
Related NICE quality standards Related NICE quality standards
Published
Cardiovascular risk assessment and lipid modification (2015) NICE quality standard 100
Secondary prevention after a myocardial infarction (2015) NICE quality standard 99
Patient experience in adult NHS services (2012) NICE quality standard 15
Chronic heart failure (2011) NICE quality standard 9. Publication update expected 2016
Future quality standards
This quality standard has been developed in the context of all quality standards referred to NICE, including the following topics scheduled for future development:
Acute medical admissions in the first 48 hours
The full list of quality standard topics referred to NICE is available from the quality standards topic library on the NICE website.
